Amyloid fibril formation by a partially structured intermediate state of α-chymotrypsin

Journal of Molecular Biology

Volumn 342, Issue 1, 2004, Pages 321-331

  Pallar̀s, Irantzu ^a   Vendrell, Josep ^a   Avilés, Francesc X ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

aggregation intermediates; amyloid formation; protein misfolding; serine proteases; TFE induced protein denaturation; chymotrypsin

Indexed keywords

AMYLOID; CHYMOTRYPSIN; SULFONIC ACID DERIVATIVE; TRIFLUOROETHANOL;

ARTICLE; BETA SHEET; CIRCULAR DICHROISM; DATA ANALYSIS; FLUORESCENCE; FOURIER TRANSFORMATION; HYDROPHOBICITY; HYPOTHESIS; INFRARED SPECTROSCOPY; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; SOLUBILITY; STRUCTURE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 4143097041     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.06.089     Document Type: Article

References (45)

1. S.Y. Tan, and M.B. Pepys Amyloidosis Histopathology 25 1994 403 414
2. C.M. Dobson The structural basis of protein folding and its links with human disease Phil. Trans. R. Soc. ser. B 356 2001 133 145
3. R.J. Ellis, and T.J. Pinheiro Medicine: danger-misfolding proteins Nature 416 2002 483 484
4. S. Ventura, E. Lacroix, and L. Serrano Insights into the origin of the tendency of the PI3-SH3 domain to form amyloidfibrils J. Mol. Biol. 322 2002 1147 1158
5. V. Villegas, J. Zurdo, V.V. Filimonov, F.X. Aviles, C.M. Dobson, and L. Serrano Protein engineering as a strategy to avoid formation of amyloid fibrils Protein Sci. 9 2000 1700 1708
6. M. Fandrich, M.A. Fletcher, and C.M. Dobson Amyloid fibrils from muscle myoglobin Nature 410 2001 165 166
7. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formgli, and J. Zurdo Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
8. J.I. Guijarro, M. Sunde, J.A. Jones, I.D. Campbell, and C.M. Dobson Amyloid fibril formation by an SH3 domain Proc. Natl Acad. Sci. USA 95 1998 4224 4228
9. S.V. Litvinovich, S.A. Brew, S. Aota, S.K. Akiyama, C. Haudenschild, and K.C. Ingham Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module J. Mol. Biol. 280 1998 245 258
10. F. Chiti, P. Webster, N. Taddei, A. Clark, M. Stefani, G. Ramponi, and C.M. Dobson Designing conditions for in vitro formation of amyloid protofilaments and fibrils Proc. Natl Acad. Sci. USA 96 1999 3590 3594
11. J.W. Kelly The environmental dependency of protein folding best explains prion and amyloid diseases Proc. Natl Acad. Sci. USA 95 1998 930 932
12. Z. Lai, W. Colon, and J.W. Kelly The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid Biochemistry 35 1996 6470 6482
13. D.R. Booth, M. Sunde, V. Belloti, C.V. Robinson, W.L. Hutchinson, and P.E. Fraser Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
14. V.N. Uversky, J. Li, and A.L. Fink Evidence for a partially folded intermediate in α-synuclein fibril formation J. Biol. Chem. 276 2001 10737 10744
15. V.J. McParland, N.M. Kad, A.P. Kalverda, A. Brown, P. Kirwin Jones, and M.G. Hunter Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro Biochemistry 39 2000 8735 8746
16. R. Khurana, J.R. Gilleppie, A. Talapatra, L.J. Minert, C. Jonesiu-Zanetti, I. Millett, and A.L. Fink Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates Biochemistry 40 2001 3525 3535
17. J.D. Harper, and P.T. Lansbury Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 355 407
18. H.T. Wright Comparison of the crystal structures of chymotrypsinogen-A and alpha-chymotrypsin J. Mol. Biol. 79 1973 1 11
19. S. Srisailam, T.K. Kumar, D. Rajalingam, K.M. Kathir, H.S. Sheu, and F.J. Jan Amyloid-like fibril formation in an all beta-barrel protein. Partially structured intermediate state(s) is a precursor for fibril formation J. Biol. Chem. 278 2003 17701 17709
20. F. Chiti, N. Taddei, M. Bucciantini, P. White, G. Ramponi, and C.M. Dobson Mutational analysis of the propensity for amyloid formation by a globular protein EMBO J. 19 2000 1441 1449
21. H. Le Vine 3rd Thioflavine T interaction with synthetic Alzheimer's disease betaamyloid peptides: detection of amyloid aggregation in solution Protein Sci. 2 1993 404 410
22. H. Le Vine 3rd Stopped-flow kinetics reveal multiple phases of thioflavin T binding to Alzheimer beta (1-40) amyloid fibrils Arch. Biochem. Biophys. 342 1997 306 316
23. I. Roterman, M. Krül, M. Nowak, L. Konieczny, J. Rybarska, and B. Stopa Why Congo red binding is specific for amyloid proteins - model studies and a computer analysis approach Med. Sci. Monit. 7 2001 771 784
24. B. Piekarska, J. Rybarska, B. Stopa, G. Zemanek, M. Krol, I. Roterman, and L. Konieczny Supramolecularity creates nonstandard protein ligands Acta Biochim. Pol. 46 1999 841 851
25. W.E. Klunk, R.F. Jacob, and R.P. Mason Quantifying amyloid by Congo red spectral shift assay Methods Enzymol. 309 1999 285 305
26. M. Sunde, and C. Blake The structure of amyloid fibrils by electron microscopy and X-ray diffraction Advan. Protein Chem. 50 1997 123 159
27. E.T. Jaikaran, C.E. Higham, L.C. Serpell, J. Zurdo, M. Gross, A. Clark, and P.E. Fraser Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis J. Mol. Biol. 308 2001 515 525
28. J. Zurdo, J.I. Guijarro, J.L. Jiménez, H.R. Saibil, and C.M. Dobson Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain J. Mol. Biol. 311 2001 325 340
29. C.E. MacPhee, and C.M. Dobson Chemical dissection and reassembly of amyloid fibrils formed by a peptide fragment of transthyretin J. Am. Chem. Soc. 122 2000 12707 12713
30. F. Chiti, N. Taddei, F. Baroni, C. Capanni, M. Stefani, G. Ramponi, and C.M. Dobson Kinetic partitioning of protein folding and aggregation Nature Struct. Biol. 9 2002 137 143
31. G.G. Glenner Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts) N. Engl. J. Med. 302 1980 1333 1343
32. B.E. Jones, P.A. Jennings, R.A. Pierre, and C. Matthews Development of non-polar surfaces in the folding of Escherichia coli dihydrofolate reductase detected by 1-anilinonaphthalene-8-sulfonate binding Biochemistry 33 1994 15250 15258
33. J. Safar, P.P. Roller, D.C. Gajdusek, and C.J. Gibbs Jr Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate Biochemistry 33 1994 8375 8383
34. J.J. Perona, and C.S. Craik Evolutionary divergente of substrate specificity within the chymotrypsin-like serine fold J. Biol. Chem. 272 1997 29987 29990
35. S. Srisailam, H.M. Wang, T.K. Kumar, D. Rajalingam, V. Sivaraja, and H.S. Sheu Amyloid-like fibril formation in an all beta-barrel protein involves the formation of partially structured intermediate(s) J. Biol. Chem. 277 2002 19027 19036
36. C.M. Dobson Protein misfolding, evolution and disease Trends Biochem. Sci. 24 1999 329 332
37. J.C. Rochet, and P. Lansbury Jr Amyloid fibrillogenesis:themes and variations Curr. Opin. Struct. Biol. 10 2000 60 68
38. R.R. Kopito, and D. Ron Conformational disease Nature Cell Biol. 2 2000 207 209
39. A.L. Fink Protein aggregation: folding aggregates, inclusion bodies and amyloid Fold. Des. 3 1998 9 23
40. K. Gast, D. Zirwer, M. Muller-Frohne, and G. Damaschun Trifluoroethanol-induced conformational transitions of proteins: insights gained from the differences between alpha-lactalbumin and ribonuclease A Protein Sci. 8 1999 625 634
41. J.W. Kelly The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways Curr. Opin. Struct. Biol. 8 1998 101 106
42. V.J. McParland, A.P. Kalverda, S.W. Homans, and S.E. Radford Structural properties of an amyloid precursor of beta(2)-microglobulin Nature Struct. Biol. 9 2002 326 331
43. M. Fändrich, V. Forge, K. Buder, M. Kittler, C.M. Dobson, and S. Diekmann Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments Proc. Natl Acad. Sci. USA 100 2003 15463 15468
44. P. Hammarstrom, F. Schneider, and J.W. Kelly Trans-suppression of misfolding in an amyloid disease Science 293 2001 2459 2462
45. P. Hammarstrom, R.L. Wiseman, E.T. Powers, and J.W. Kelly Prevention of transthyretin amyloid disease by changing protein misfolding energetics Science 299 2003 713 716